| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | Common | G46188101 | $985,860 | 9,000,000 | SOLE | |||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | $884,550 | 5,000,000 | SOLE | |||
| ACCELERON PHARMA INC | Common | 00434H108 | $688,432 | 4,476,100 | SOLE | |||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | $553,740 | 3,000,000 | SOLE | |||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | $315,592 | 1,980,000 | SOLE | |||
| ARGENX SE | Sponsored ADR | 04016X101 | $285,843 | 946,500 | SOLE | |||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | $233,394 | 2,700,000 | SOLE | |||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | $211,150 | 9,150,000 | SOLE | |||
| ARENA PHARMACEUTICALS INC | Common | 40047607 | $203,959 | 3,425,000 | SOLE | |||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | $168,837 | 17,679,273 | SOLE | |||
| APELLIS PHARMACEUTICALS INC | Common | 03753U106 | $166,060 | 6,515,000 | SOLE | |||
| ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | $160,489 | 850,000 | SOLE | |||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | $144,919 | 1,875,000 | SOLE | |||
| VERTEX PHARMACEUTICALS INC | Common | 92532F100 | $120,443 | 664,000 | SOLE | |||
| IVERIC BIO INC | Common | 46583P102 | $115,304 | 7,100,000 | SOLE | |||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | $113,701 | 1,425,000 | SOLE | |||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | $100,092 | 5,700,000 | SOLE | |||
| PMV PHARMACEUTICALS INC | Common | 69353Y103 | $87,165 | 2,925,000 | SOLE | |||
| KURA ONCOLOGY INC | Common | 50127T109 | $74,920 | 4,000,000 | SOLE | |||
| MERSANA THERAPEUTICS INC | Common | 59045L106 | $64,124 | 6,800,000 | SOLE | |||
| MONTE ROSA THERAPEUTICS INC | Common | 61225M102 | $61,003 | 3,311,434 | SOLE | |||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | $55,772 | 3,650,000 | SOLE | |||
| AADI BIOSCIENCES INC | Common | 00032Q104 | $53,730 | 1,829,402 | SOLE | |||
| MANNKIND CORP | Common | 56400P706 | $38,280 | 8,800,000 | SOLE | |||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | $37,595 | 10,300,000 | SOLE | |||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | $36,814 | 3,235,000 | SOLE | |||
| ACADIA PHARMACEUTICALS INC | Common | 4225108 | $36,542 | 2,200,000 | SOLE | |||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | $36,291 | 1,068,000 | SOLE | |||
| AMARIN CORP PLC | Sponsored ADR | 23111206 | $30,600 | 6,000,000 | SOLE | |||
| PRAXIS PRECISION MEDICINES INC | Common | 74006W108 | $29,584 | 1,600,000 | SOLE | |||
| SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | $29,525 | 1,545,000 | SOLE | |||
| AVIDITY BIOSCIENCES INC | Common | 05370A108 | $28,325 | 1,150,000 | SOLE | |||
| KYMERA THERAPEUTICS INC | Common | 501575104 | $26,771 | 455,750 | SOLE | |||
| DICE THERAPEUTICS INC | Common | 23345J104 | $26,200 | 800,000 | SOLE | |||
| BIOGEN INC | Common | 09062X103 | $23,771 | 84,000 | SOLE | |||
| AVADEL PHARMACEUTICALS PLC | Sponsored ADR | 05337M104 | $22,295 | 2,275,000 | SOLE | |||
| NUVALENT INC | Common | 670703107 | $22,288 | 1,257,671 | SOLE | |||
| DESIGN THERAPEUTICS INC | Common | 25056L103 | $21,570 | 1,468,318 | SOLE | |||
| TANGO THERAPEUTICS INC | Common | 87583X109 | $20,042 | 1,550,000 | SOLE | |||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | $15,731 | 1,670,000 | SOLE | |||
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | $15,082 | 6,950,000 | SOLE | |||
| MERUS N V | Common | N5749R100 | $9,900 | 450,000 | SOLE | |||
| GENOCEA BIOSCIENCES INC | Common | 372427401 | $9,762 | 5,084,184 | SOLE |